Developing new methods to create complex natural compounds called isoprenoids
A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds
['FUNDING_R01'] · UNIVERSITY OF OKLAHOMA · NIH-10993670
This study is working on making special compounds called isoprenoids that are used in medicine and industry, with the hope that these new methods will lead to better treatments for patients in the future.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF OKLAHOMA (nih funded) |
| Locations | 1 site (NORMAN, UNITED STATES) |
| Trial ID | NIH-10993670 on ClinicalTrials.gov |
What this research studies
This research focuses on creating isoprenoids, which are important compounds used in medicine and industry. The project aims to develop efficient strategies for synthesizing both natural and synthetic versions of these compounds using advanced techniques in metabolic engineering and synthetic biology. By employing specific enzymes and innovative methods, the researchers hope to overcome challenges related to traditional extraction and synthesis processes. Patients may benefit from new therapies derived from these isoprenoids in the future.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated with isoprenoid-derived therapies.
Not a fit: Patients who do not have conditions related to isoprenoid applications may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies and products derived from isoprenoids, improving treatment options for various medical conditions.
How similar studies have performed: While metabolic engineering and synthetic biology have shown promise in similar areas, this specific approach to synthesizing isoprenoids is relatively novel and untested.
Where this research is happening
NORMAN, UNITED STATES
- UNIVERSITY OF OKLAHOMA — NORMAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SINGH, SHANTERI — UNIVERSITY OF OKLAHOMA
- Study coordinator: SINGH, SHANTERI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.